Prospective Multi-Center Trial for FemBloc Permanent Birth Control
ConditionContraception
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-50
SponsorFemasys Inc.
About this trial
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Eligibility criteria
Qualifiers
Female, 21 - 50 years of age desiring permanent birth control.
Sexually active with male partner.
Regular menstrual cycle for last 3 months or on hormonal contraceptives.
Disqualifiers
Uncertainty about the desire to end fertility.
Known or suspected pregnancy.
Prior tubal surgery, including sterilization attempt.
Presence, suspicion, or previous history of gynecologic malignancy.
Trial design
Treatments tested in this trial
- FemBloc
Treatment groups
573 Participants
are divided into 1 treatment groupLocations
8Arizona
New Horizons Clinical Trials85224, Chandler United States
California
Stanford University94304, Palo Alto United States
University of California Davis95817, Sacramento United States
Georgia
Midtown OB GYN North31909, Columbus United States
Sponsors and collaborators
Femasys Inc.
Lead sponsor
Source ClinicalTrials.gov